HAOHAI BIOTEC

06826
15.7000.51% ( -0.080 )
Delay Closed: Nov 17, 16:08:15

Valuation

Current ValuationThe current P/E ratio is 28.23, above the reasonable range, cheaper than 6.52% of the time in the past 5 years, and the industry ranks 18/78, the industry Median -4.90.

28.23xP/E
Stock priceHK$15.70Earnings per shareHK$0.56

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0150300450600

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
02696HKHENLIUS
23.96x25.47%HK$23.93B
02162HKKEYMED BIO-B
22.92x248.55%HK$20.42B
02157HKLEPU BIO
16.56x127.52%HK$4.71B
06826HKHAOHAI BIOTEC
28.23x128.83%HK$3.59B
02181HKMABPHARM-B
20.71x--HK$2.04B
06915HKJIANGXI BIO
19.44x--HK$1.62B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.